• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prescribing of anticancer drugs in renal impairment: why can't we do better?

作者信息

Abdel-Kahaar Emaad, Zolk Oliver

机构信息

Institute of Pharmacology of Natural Products and Clinical Pharmacology, University Hospital Ulm, Helmholtzstr. 20, 89081, Ulm, Germany.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2018 Feb;391(2):107-109. doi: 10.1007/s00210-017-1461-5. Epub 2018 Jan 6.

DOI:10.1007/s00210-017-1461-5
PMID:29307010
Abstract
摘要

相似文献

1
Prescribing of anticancer drugs in renal impairment: why can't we do better?肾功能损害患者的抗癌药物处方：我们为何不能做得更好？
Naunyn Schmiedebergs Arch Pharmacol. 2018 Feb;391(2):107-109. doi: 10.1007/s00210-017-1461-5. Epub 2018 Jan 6.
2
Drug prescribing in kidney disease: can't we do better?肾病中的药物处方：我们难道不能做得更好吗？
Am J Kidney Dis. 2014 Mar;63(3):382-3. doi: 10.1053/j.ajkd.2013.11.011.
3
You can't be too careful with cytotoxic drugs.使用细胞毒性药物再小心也不为过。
RN. 1985 Feb;48(2):71-2.
4
An institutional approach to the management of the 'Can't Intubate, Can't Oxygenate' emergency in children.儿童“无法插管、无法给氧”紧急情况管理的机构性方法。
Paediatr Anaesth. 2016 Aug;26(8):784-93. doi: 10.1111/pan.12926. Epub 2016 Jun 9.
5
Community based rehabilitation programmes: monitoring and evaluation in order to measure results.基于社区的康复计划：进行监测和评估以衡量结果。
Lepr Rev. 2008 Mar;79(1):36-49.
6
Use of sugammadex in a 'can't intubate, can't ventilate' situation.在“无法插管，无法通气”的情况下使用琥珀酰明胶。
Br J Anaesth. 2012 Apr;108(4):612-4. doi: 10.1093/bja/aer494. Epub 2012 Jan 26.
7
T-cell chauvinists versus antibody advocates--can't we all just get along?T细胞沙文主义者与抗体倡导者——难道我们就不能和睦相处吗？
J Clin Oncol. 2004 Nov 15;22(22):4446-8. doi: 10.1200/JCO.2004.06.939. Epub 2004 Oct 13.
8
Metastatic potential of the small renal mass: why can't we agree?小肾肿物的转移潜能：为何我们无法达成共识？
Eur Urol. 2011 Nov;60(5):983-5; discussion 985-6. doi: 10.1016/j.eururo.2011.07.004. Epub 2011 Jul 12.
9
Why can't we do a better job controlling rheumatoid arthritis?为什么我们在控制类风湿性关节炎方面不能做得更好？
Ala Med. 1986 Sep;56(3):40-4.
10
The Myth of Rescue Reversal in "Can't Intubate, Can't Ventilate" Scenarios.“无法插管，无法通气”情况下救援逆转的神话。
Anesth Analg. 2016 Jul;123(1):82-92. doi: 10.1213/ANE.0000000000001347.

引用本文的文献

1
Justifying Ribociclib Dose in Patients with Advanced Breast Cancer with Renal Impairment Based on PK, Safety, and Efficacy Data: An Innovative Approach Integrating Data from a Dedicated Renal Impairment Study and Oncology Clinical Trials.基于药代动力学、安全性和疗效数据，为肾功能损害的晚期乳腺癌患者提供瑞博西利剂量合理性依据：一项整合专门肾功能损害研究和肿瘤学临床试验数据的创新方法。
Clin Pharmacokinet. 2023 Mar;62(3):493-504. doi: 10.1007/s40262-022-01206-2. Epub 2023 Feb 17.

本文引用的文献

1
Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety.根据肾功能调整顺铂、依托泊苷和异环磷酰胺的剂量：回顾性分析及对药物安全性的影响。
Naunyn Schmiedebergs Arch Pharmacol. 2018 Feb;391(2):219-229. doi: 10.1007/s00210-017-1456-2. Epub 2018 Jan 2.
2
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家发病率、患病率以及 195 个国家和地区 1990 年至 2016 年 328 种疾病和伤害导致的残疾年数：2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2.
3
A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development strategies and future directions.2010年至2015年初美国新肿瘤药物获批的肾功能损害药代动力学研究调查：聚焦于开发策略与未来方向
Anticancer Drugs. 2017 Aug;28(7):677-701. doi: 10.1097/CAD.0000000000000513.
4
Renal insufficiency and cancer treatments.肾功能不全与癌症治疗。
ESMO Open. 2016 Aug 18;1(4):e000091. doi: 10.1136/esmoopen-2016-000091. eCollection 2016.
5
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.全球慢性肾脏病患病率——一项系统评价与荟萃分析
PLoS One. 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765. eCollection 2016.
6
Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.慢性肾脏病及需要透析的患者的药代动力学考量
Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1131-43. doi: 10.1517/17425255.2014.931371. Epub 2014 Jun 24.
7
Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources?肾功能损害患者药物剂量调整指南：药物信息来源的一致性如何？
Intern Med J. 2014 Jan;44(1):77-85. doi: 10.1111/imj.12291.
8
Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).急慢性肾脏病患者的药物剂量考虑——KDIGO（改善全球肾脏病预后组织）的临床更新。
Kidney Int. 2011 Dec;80(11):1122-37. doi: 10.1038/ki.2011.322. Epub 2011 Sep 14.